Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Blocking Oncogene Can Stop Spread of Ovarian Cancer

Lab study showed it had effect on 60% Of malignant cells


Related Encyclopedia
 border=
Adenocarcinoma of the Lung and Brain Metastases
Amenorrhea
Amniocentesis
Amniocentesis and CVS
More...

Related Healthscout Videos
 border=
Optimistic Healing
Early Babies: How Soon is Too Soon?
Aqua Lipo
Cancer Treatment for Any Size
More...

Related Animations
 border=
Breast Reduction
Breast Self-Exam Video
Colon Cancer
Erectile Dysfunction
More...

Related Drug Information
 border=
Actonel
Detrol LA
Diflucan
Ditropan XL
More...

Related News Articles
 border=
Focusing on School Could Prevent Teen Pregnancies
Low Vitamin D Tied to Estrogen Decline
Caring Through Sharing -- Life Changing Stories
Breast Cancer Pain Continues Years After Treatment
More...

MONDAY, Dec. 15 (HealthDay News) -- Blocking proteins produced by the oncogene MYC can stop the spread of ovarian cancer, researchers say.

An oncogene is a gene that has the potential to help cause cancer.

Text Continues Below



In up to 60 percent of human ovarian tumors, MYC is overly active. This causes the ovarian cells to produce excessive c-Myc, a protein regulator of other genes involved in cell growth, which leads to proliferation of the cancer cells.

University of California, Berkeley, researchers halted the spreading in lab cultures of human ovarian cancer cells with amplified MYC by using RNA interference (RNAi) to block c-Myc protein. They then used small interfering RNA (siRNA) to halt L-Myc and N-Myc proteins, a process that halted the growth of the non-amplified MYC tumors.

The therapies had no effect on lab cultures of normal ovarian surface epithelial cells, leading them to theorize that the RNAi and siRNA treatments are effective only when the MYC genes are abnormally active.

The findings are scheduled to be presented Monday at the American Society for Cell Biology annual meeting, in San Francisco.

More information

The National Ovarian Cancer Coalition has more about ovarian cancer.



-- Kevin McKeever

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 12/15/2008

Related Links
 border=
From Healthscout's partner site on breast cancer, MyBreastCancerNetwork.com
VIDEO: Chemo booster cuts treatment time by two months
SYMPTOMS: Learn what to look for and what the symptoms mean
PROGNOSIS: Early detection and new treatments improve survival rates





SOURCE: American Society for Cell Biology, news release, Dec. 14, 2008


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy